Muscular dystrophy is a kind of hereditary muscle degenerative disease, usually with progressive muscle atrophy and muscle weakness, which seriously affects daily life. With an in-depth understanding of the pathological mechanism of muscular dystrophy in modern medicine, new therapeutic targets have been continuously discovered, which provides more possibilities for the development of anti-muscular dystrophy drugs.
Protheragen offers a full range of anti-muscular dystrophy APIs to support development and production for customers worldwide.
Cat | Product Name | Cas | Details | Chemical Structure |
---|---|---|---|---|
API1258984369 | Nusinersen(ASO, Oligonucleotides) | 1258984-36-9 | View Details |
![]() |
API1825352655 | Risdiplam | 1825352-65-5 | View Details |
![]() |
Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed